R. Brachmann
Impact in
-
- Fungal and yeast genetics research
- Bioinformatics and Genomic Networks
- RNA and protein synthesis mechanisms
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- Genomics and Chromatin Dynamics
- Microbial Metabolic Engineering and Bioproduction
Papers in
- Oncology 12
- Cancer Treatment and Pharmacology 3
- PARP inhibition in cancer therapy 3
- Lymphatic System and Diseases 2
- Cancer-related Molecular Pathways 2
- Pancreatic and Hepatic Oncology Research 2
-
- Angiogenesis and VEGF in Cancer 4
- Co-authors
- Jef D. Boeke (2 shared papers)Marc Vidal (2 shared papers)Ali Fattaey (1 shared paper)Ed Harlow (1 shared paper)Colin D. Weekes (6 shared papers)Georg Fuchs (1 shared paper)S.W. Ragsdale (1 shared paper)Carlos Gomez‐Roca (3 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Annals of Oncology (5 papers)Proceedings of the National Academy of Sciences (2 papers)European Journal of Cancer (2 papers)IEEE/ACM Transactions on Computational Biology and Bioinformatics (1 paper)
- Partner nations
- United StatesChinaSpain
In The Last Decade
R. Brachmann
16 papers receiving 610 citations
Peers
Comparison fields: 5 of 76
- Aging 14
- Molecular Biology 524
- Oncology 155
- Cell Biology 76
- Biotechnology 32
Countries citing papers authored by R. Brachmann
This map shows the geographic impact of R. Brachmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Brachmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Brachmann more than expected).
Fields of papers citing papers by R. Brachmann
This network shows the impact of papers produced by R. Brachmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Brachmann. The network helps show where R. Brachmann may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Brachmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 370 | |
| 2 | 1996 | 143 | |
| 3 | 2006 | 24 | |
| 4 | 2011 | 19 | |
| 5 | 2016 | 16 | |
| 6 | 1995 | 14 | |
| 7 | 2016 | 12 | |
| 8 | 2011 | 11 | |
| 9 | 2011 | 10 | |
| 10 | 2010 | 5 | |
| 11 | 2010 | 4 | |
| 12 | [Administration of prostaglandin E1 in diabetics and non-diabetic patients with severe Fontaine stage IIb arterial occlusive disease]. | 1991 | 2 |
| 13 | 2010 | 2 | |
| 14 | 2018 | 2 | |
| 15 | 2012 | 2 | |
| 16 | 2018 | 1 | |
| 17 | 2011 | 1 | |
| 18 | 2018 | 0 |
About R. Brachmann
R. Brachmann is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Epidemiology, having authored 18 papers that have together received 638 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), Cancer Treatment and Pharmacology (3 papers), PARP inhibition in cancer therapy (3 papers), Lymphatic System and Diseases (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Cancer-related Molecular Pathways (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Aging (14 citations), Molecular Biology (524 citations), Oncology (155 citations), Cell Biology (76 citations) and Biotechnology (32 citations). R. Brachmann has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Jef D. Boeke, Marc Vidal, Ali Fattaey, Ed Harlow, Colin D. Weekes, Georg Fuchs, S.W. Ragsdale, Carlos Gomez‐Roca, Harry J.M. Groen and Alex A. Adjei. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Proceedings of the National Academy of Sciences, European Journal of Cancer and IEEE/ACM Transactions on Computational Biology and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.